Jazz Pharmaceuticals shared a post on LinkedIn by Recursion, adding:
“We’re proud to have our CEO, Renee Gala, representing Jazz at the 44th J.P. Morgan Healthcare Conference. This week, she joined the Techbio Talks Live panel to discuss the intersection of Tech, AI, and Healthcare and how innovation can accelerate the delivery of meaningful medicines to patients.
At Jazz, we believe collaboration across science and technology is key to driving patient impact.”
Quoting Recursion’s post:
“We were honored to host a packed TechBio Talks Live event at the San Francisco Mint last night, with an introduction from CEO and President Najat Khan, PhD, and a fireside chat with Najat and award-winning journalist, filmmaker, podcaster, and co-founder of Stand Up To Cancer, Katie Couric.
Katie moderated a panel discussion on the future of AI in healthcare and medicine featuring:
- Renee Gala, President and CEO of Jazz Pharmaceuticals
- Reid Hoffman, Co-founder, LinkedIn, Manas AI, and Inflection AI
- Eric Lefkofsky, Founder and CEO, Tempus AI
- Eric Topol, MD, Chair, Department of Translational Medicine, Scripps Research
They discussed the best places to deploy capital to drive AI innovation in healthcare; how to distinguish clinical impact from AI hype; and how technology is positioned to impact patients.
Thank you to all the panelists and guests who attended – we’ll be sharing more highlights and videos from this incredible night in the weeks to come!”
More posts from JPM26 on OncoDaily.
